Get live updates and the latest news as Trump marks the launch of Trump Accounts for children, the NAACP expands its midterm ...
Genmab A/S(Nasdaq: GMAB) announced today that the European Commission (EC) granted marketing authorization for TEPKINLY ® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R 2 ) ...
Some repeated low-level red light therapy devices for myopia control may not meet safety standards for lasers and ophthalmic ...
Canadian startup Reflect10 has unveiled a photovoltaic module architecture that it claims boosts average daily energy ...